Clinical Review

Insulin Types Chart: Onset, Peak and Duration + Mixing Rules

Quick answer: Insulin types differ in how fast they start, peak and wear off. Rapid-acting (lispro, aspart, glulisine) starts in 10-30 minutes, peaks at about 1 hour and lasts 3-5 hours. Regular starts in 30-60 minutes, peaks at 2-3 hours and lasts 5-8 hours. NPH starts in 1-2 hours, peaks at 4-12 hours and lasts 12-18 hours. Glargine, detemir and degludec are essentially peakless basal insulins (detemir, sold as Levemir, was discontinued in the U.S. at the end of 2024 but still appears in older questions).

Insulin questions almost always hinge on one number: the peak. The peak is when blood glucose drops the hardest. That makes it the window where your patient is most likely to go hypoglycemic, and the time you watch them and feed them most carefully. Rapid-acting insulin peaks in about an hour, regular in 2-3 hours, NPH in 4-12 hours, and the long-acting basal insulins (glargine, detemir, degludec) are essentially peakless. Learn the chart below, learn “clear before cloudy,” and remember that Regular is the insulin you hang as an IV drip.

Insulin types chart: onset, peak, and duration

These are the standard reference values for subcutaneous insulin in an adult. Ranges vary a little by source and by the individual patient, but the numbers below are the defensible, testable values you should commit to memory. The single most important column is the peak, because that is where hypoglycemia lives.

Category Examples Onset Peak Duration
Rapid-acting Lispro, aspart, glulisine 10-30 min 30 min-3 hr (about 1 hr) 3-5 hr
Short-acting (Regular) Regular insulin (R) 30-60 min 2-3 hr 5-8 hr
Intermediate-acting NPH (N) 1-2 hr 4-12 hr 12-18 hr
Long-acting (basal) Glargine, detemir 1-2 hr Peakless (no pronounced peak) Up to 24 hr
Ultra-long-acting (basal) Degludec 1-2 hr Peakless Over 42 hr
Premixed 70/30, 75/25, 50/50 (NPH + rapid/regular) 10-30 min (analog mixes 10-20 min; human 70/30 ~30-60 min) Dual peak (early + later) 10-16 hr

A quick mnemonic for the color cue: rapid and regular insulins are clear; NPH is cloudy because the protamine suspended in it scatters light. Glargine and detemir are also clear, but do not let “clear” trick you into mixing them with anything (more on that below).

How do you read the chart in real life?

Match the insulin to the patient’s needs over the day. Rapid-acting covers the spike from a single meal, so it is given right at the start of eating. Regular covers a meal too but works more slowly, so it is given about 30 minutes before food. NPH and the long-acting insulins are basal, holding glucose down between meals and overnight. Premixed products try to do both jobs in one injection, which is convenient but less flexible.

When will my patient get hypoglycemic? Tie it to the peak

This is the concept the exam tests over and over. Hypoglycemia is most likely at the insulin’s peak, because that is when the most insulin is active and pulling glucose into cells. Your job is to make sure food and monitoring line up with that window.

Insulin given at… Peak (highest hypoglycemia risk) Watch and feed by…
Rapid-acting (lispro) with breakfast at 0800 ~0900 (about 1 hr later) The tray must be in front of the patient before you inject
Regular at 0730, 30 min before breakfast ~0930-1030 (2-3 hr later) Mid-to-late morning; watch before the noon meal
NPH at 0800 1200-2000 (4-12 hr later) Lunch and the afternoon; classic late-afternoon lows
NPH at bedtime (2100) 0100-0900 overnight The dreaded nocturnal hypoglycemia window
Glargine/detemir/degludec No pronounced peak Lower, steadier risk; no single feed-by spike

This table points to two clinical pearls. First, rapid-acting insulin and the meal tray are a package deal: give the insulin only when you can confirm the patient is going to eat. Hold it (and check with the provider) if the patient is NPO, nauseated, or has a tray that may not arrive. Second, bedtime NPH is the usual culprit behind a patient found diaphoretic and confused at 0300; that is the NPH peaking overnight.

What does “peakless” really mean for long-acting insulin?

Glargine, detemir, and degludec release slowly and steadily, so they produce a relatively flat level with no sharp peak. That flat profile is the whole point: it mimics the body’s basal insulin and carries a lower risk of sudden lows. It does not mean zero hypoglycemia risk, especially if the patient skips meals or stacks doses, but there is no single hour you circle on the clock the way you do with NPH. For that reason these are usually dosed once daily, though detemir is dose-dependent and may be ordered twice daily (degludec is forgiving on timing because it lasts over 42 hours).

Insulin mixing rules: clear before cloudy

When a patient needs both a short-acting and an intermediate-acting insulin in one syringe, the only standard combination you mix is Regular + NPH. The rule for drawing them up is clear before cloudy: draw the clear Regular insulin into the syringe first, then the cloudy NPH.

Why clear before cloudy?

If a little of the cloudy NPH (which contains protamine) gets pushed back into the Regular vial, it can contaminate your fast-acting insulin and blunt how quickly it works. Drawing the clear Regular first protects that vial. The full sequence is worth memorizing as a skills-checkoff and an NCLEX ordered-response item:

Step Action
1 Wash hands; gently roll the cloudy NPH between your palms to resuspend it (do not shake)
2 Wipe both vial tops with alcohol
3 Inject air equal to your dose into the NPH (cloudy) vial first, then withdraw the needle without drawing up insulin
4 Inject air equal to your dose into the Regular (clear) vial
5 Draw up the Regular (clear) insulin first
6 Then draw up the NPH (cloudy) insulin

Keep the two sequences straight: you inject air into the cloudy vial first, but you draw insulin out of the clear vial first. Air goes cloudy-then-clear; insulin comes out clear-then-cloudy. Once the two are mixed in the syringe, administer promptly.

Which insulins must NEVER be mixed?

Glargine and detemir must never be mixed with any other insulin in the same syringe. Glargine is formulated at an acidic pH and precipitates the moment it meets a neutral-pH insulin; detemir depends on binding to albumin for its long action, and mixing disrupts that profile. Either way absorption becomes unpredictable, so they always get their own injection. Premixed products (such as 70/30) are pre-formulated by the manufacturer and are not mixed further at the bedside. Degludec is also given on its own. When in doubt, the safe answer on a test and at the bedside is: do not mix a long-acting basal insulin with anything.

Combination Mix in one syringe?
Regular + NPH Yes, clear (Regular) before cloudy (NPH)
Rapid-acting (lispro/aspart) + NPH Generally yes if ordered, draw rapid first; give immediately
Glargine (Lantus) + anything No, never
Detemir (Levemir) + anything No, never
Degludec + anything No, give separately

Which insulin can be given IV?

Regular insulin is the insulin given intravenously. It is the insulin used in continuous IV drips for diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state, and it is given as an IV dose for severe hyperkalemia (paired with dextrose to drive potassium into cells). NPH and the long-acting insulins are subcutaneous only — they are suspensions or designed for slow subcutaneous release and would be dangerous given IV. (Rapid-acting analog labels do carry IV dosing instructions for diluted, supervised infusion, but Regular is the standard agent and the expected exam answer.) If a question asks which insulin can hang as a drip, the answer is Regular, every time.

One more high-yield point on administration: insulin is measured in units, drawn up in an insulin syringe, and double-checked by a second nurse per facility policy because it is a high-alert medication. Subcutaneous insulin is given at a 90-degree angle (45 degrees in a very thin patient), and you rotate sites within one anatomic region rather than scattering across the body.

Studying insulin?
Put it to the test with NCLEX-style practice questions — free, full rationale on every answer. No credit card.

Start practicing →

Recognizing and treating hypoglycemia

Because insulin’s peak is a hypoglycemia trigger, you have to know the signs and the fix cold. Early hypoglycemia is adrenergic: shakiness, sweating, tachycardia, hunger, anxiety. As glucose falls further it becomes neuroglycopenic: confusion, slurred speech, seizures, loss of consciousness. The treatment threshold is a blood glucose below 70 mg/dL.

For a conscious patient who can swallow, follow the rule of 15: give 15 grams of fast-acting carbohydrate (4 oz juice, glucose tablets, regular soda), recheck the glucose in 15 minutes, and repeat if it is still below 70. Follow up with a protein-plus-carb snack once the level recovers to prevent a rebound drop. For an unconscious patient or one who cannot safely swallow, give IV dextrose (D50) if there is IV access, or IM/subcutaneous glucagon if there is not. Never pour food or fluid into the mouth of someone who is not alert.

For a fuller walk-through of diabetes, DKA, and the rest of the hormones, work through our NCLEX endocrine review. And because insulin is a high-alert drug, it pairs naturally with our therapeutic drug levels and toxicity guide, which covers the other medications you have to monitor by the numbers.

Sample NCLEX insulin questions

Sample question 1

A nurse administers lispro insulin to a client at 0730. At what time should the nurse be most alert for signs of hypoglycemia?

  1. 0745
  2. 0830
  3. 1130
  4. 1530
Show answer & rationale

Correct answer: B. Lispro is rapid-acting and peaks roughly one hour after administration, so about 0830 is the highest-risk window. Option A is too early; the insulin has only just started to act at its onset. Option C, at 1130, sits at the tail end of lispro’s 3-5 hour duration, and option D, at 1530, falls well past it, so by either point the dose is essentially gone and the acute risk has passed. What anchors the answer is the peak, not the onset or the dose, marking the hypoglycemia window.

Sample question 2

The nurse is preparing to draw up Regular and NPH insulin in a single syringe. Place the steps in the correct order.

  1. Inject air into the NPH vial, inject air into the Regular vial, draw up Regular, draw up NPH
  2. Inject air into the Regular vial, draw up Regular, inject air into the NPH vial, draw up NPH
  3. Draw up NPH first, then draw up Regular
  4. Inject air into the Regular vial, draw up NPH, then draw up Regular
Show answer & rationale

Correct answer: A. Air is injected into the cloudy NPH vial first (without withdrawing insulin), then into the clear Regular vial; the clear Regular is drawn up before the cloudy NPH. Option B injects air into the NPH vial after the Regular insulin is already in the syringe, so depressing the plunger pushes Regular insulin out into the NPH vial and wrecks the measured dose. Injecting air into both vials before withdrawing anything is exactly what prevents that. Options C and D violate “clear before cloudy” by drawing or sequencing the cloudy insulin too early, which can blunt the fast-acting Regular.

Sample question 3

A client with diabetic ketoacidosis is admitted to the ICU. Which insulin does the nurse anticipate administering by continuous IV infusion?

  1. NPH insulin
  2. Insulin glargine
  3. Insulin detemir
  4. Regular insulin
Show answer & rationale

Correct answer: D. Regular insulin is the standard agent for IV administration, making it the insulin used in DKA drips. NPH is a cloudy suspension and the long-acting basal insulins (glargine, detemir) are designed for slow subcutaneous absorption; giving any of them IV is unsafe and would not deliver the rapid, titratable control DKA requires. If it hangs as a drip, it is Regular.

Sample question 4 (Select all that apply)

A nurse is teaching a newly diagnosed client about insulin. Which statements by the client indicate correct understanding? Select all that apply.

  • A. “I will take my rapid-acting insulin right when I start eating.”
  • B. “I can mix my glargine with my Regular insulin to save an injection.”
  • C. “My NPH looks cloudy, so I will gently roll it between my hands before drawing it up.”
  • D. “If my blood sugar is below 70, I’ll eat 15 grams of carbs and recheck in 15 minutes.”
  • E. “I should give my full mealtime rapid-acting insulin even on mornings I’m too nauseated to eat anything.”
Show answer & rationale

Correct answers: A, C, D. Rapid-acting insulin is timed to the meal (A); NPH is a suspension that must be gently resuspended, not shaken (C); and the rule of 15 is the correct response to a glucose under 70 (D). Statement B is dangerous because glargine must never be mixed with any other insulin. Statement E is wrong because giving a full mealtime rapid-acting dose without eating sets the client up for hypoglycemia at the peak. Note the distinction: sick-day rules say never omit basal (long-acting) insulin when ill — illness raises glucose through counter-regulatory hormones, and skipping basal insulin is a leading cause of DKA. It is the mealtime rapid-acting dose that is held or reduced when no carbohydrate is taken. The client should continue basal insulin, check glucose every 3-4 hours, monitor ketones, sip carbohydrate-containing fluids, and contact the provider if unable to keep food or fluids down.

Frequently Asked Questions

What is the most important thing to know about insulin for the NCLEX?

The peak. The peak is when blood glucose drops most sharply and when hypoglycemia is most likely, so it drives your monitoring and your meal timing. If you know that rapid-acting peaks around 1 hour, regular at 2-3 hours, and NPH at 4-12 hours, you can answer most “when will hypoglycemia occur” and “when should the client eat” questions correctly.

Which insulins are clear and which are cloudy?

Rapid-acting (lispro, aspart, glulisine), Regular, glargine, and detemir are all clear. NPH is the cloudy one because it contains protamine in suspension. When mixing Regular with NPH, the rule “clear before cloudy” means you draw up the clear Regular before the cloudy NPH. Note that glargine and detemir are clear but are never mixed with anything.

Can you mix any two insulins together?

The standard mixable combination is Regular plus NPH, drawn clear before cloudy. Rapid-acting insulin may also be mixed with NPH if ordered, drawing the rapid insulin first and giving the mix immediately. Glargine, detemir, and degludec are never mixed with another insulin in the same syringe, and premixed products are not combined further.

Which insulin can be given IV?

Regular insulin — it is the standard agent and the expected exam answer. It is the insulin used in continuous IV infusions for diabetic ketoacidosis, hyperosmolar hyperglycemic state, and as part of the treatment for severe hyperkalemia with dextrose. NPH and the long-acting basal insulins are subcutaneous only.

Why is long-acting insulin called “peakless”?

Glargine, detemir, and degludec release at a slow, steady rate that produces a relatively flat blood level with no sharp spike. That flat profile mimics the body’s basal insulin secretion and carries a lower risk of sudden hypoglycemia. There is no single peak hour to plan a feeding around, which is why these are typically dosed once daily — though detemir may be ordered twice daily.

Want to lock these numbers in until they are automatic? Practice free NCLEX questions with full rationales for every answer choice, right and wrong, no credit card required.

Practice questions like these

Put it to the test with NCLEX-style practice questions — free, full rationale on every answer. No credit card.

Start Practicing Free

Sources

Sources checked September 2026.